Journal profile · ENGINEERING, BIOMEDICAL
Advanced Biomedical Engineering
ISSN 2187-5219 · Japanese Society for Medical and Biological Engineering · Japan
Advanced Biomedical Engineering: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 300; review about 15 weeks (community reports); 43 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Advanced Biomedical Engineering is published by Japanese Society for Medical and Biological Engineering and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Non-Invasive Vital Sign Monitoring, EEG and Brain-Computer Interfaces and Muscle activation and electromyography studies, together about 24.9% of its articles. Its main subfields are Biomedical Engineering. (generated from OpenAlex topic counts and CAS ranking data)
Advanced Biomedical Engineering (ABE) is an international, Open Access and fully peer-reviewed journal covering all areas of biomedical engineering. Supported by the Japanese Society for Medical and Biological Engineering (JSMBE), the journal aims to be a forum for exchanging information on new developments and ideas. ABE welcomes manuscripts describing rigorous research on topics including: biomedical signal processing and imaging bio-instrumentation and sensors applications informatics in healthcare and biomedicine cardiovascular and respiratory systems engineering neural and rehabilitation engineering cellular and tissue engineering biomechanics and robotics therapeutic and diagnostic technology clinical engineering regulatory science in biomedical engineering. ABE publishes Review Papers, Original Papers, Research Letters and Technical Notes, which are freely available online. The journal’s broad international audience includes biomedical engineers, clinicians, nurses, medical specialists (co-medicals) and regulatory authorities. Graduate students and young investigators, in particular those from developing countries, are encouraged to submit their manuscripts to ABE.
From the journal's Aims & Scope
Research area (LetPub): ENGINEERING, BIOMEDICAL
Editor-in-chief Yutaka FukuokaPublisher website
Editorial board by country: 3 in mainland China (about 4%); most named Japan 47, United States 9, Mainland China 3, United Kingdom 2, Australia 2 (69 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Non-Invasive Vital Sign MonitoringEngineering10.1%
- EEG and Brain-Computer InterfacesNeuroscience8.2%
- Muscle activation and electromyography studiesEngineering6.6%
- Heart Rate Variability and Autonomic ControlMedicine5.6%
- Neuroscience and Neural EngineeringNeuroscience4.8%
- Photoacoustic and Ultrasonic ImagingEngineering4.5%
- Functional Brain Connectivity StudiesNeuroscience4%
- Optical Imaging and Spectroscopy TechniquesMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Engineering, Biomedical | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Engineering, Biomedical | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceINSPECPublisher website
Other: Google Scholar, Dimensions
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2022
- 1Publisher website ·
- CiteScore 2026-06
- 1.2LetPub ·
- CiteScore (publisher) 2022
- 1.5Publisher website ·
- SJR 2026-06
- 0.21LetPub ·
- SJR (publisher) 2022
- 0.29Publisher website ·
- SNIP 2026-06
- 0.48LetPub ·
- SNIP (publisher) 2022
- 0.58Publisher website ·
- h-index
- 17OpenAlex ·
- i10-index
- 42OpenAlex ·
- 2-year mean citedness
- 0.57OpenAlex ·
- Self-citation rate
- 28.6%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 42LetPub ·
Articles by year OpenAlex count · 429 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 54 | 54 | 1 |
| 2025 | 43 | 43 | 32 |
| 2024 | 45 | 45 | 48 |
| 2023 | 28 | 28 | 84 |
| 2022 | 25 | 25 | 99 |
| 2021 | 18 | 18 | 68 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 15 weeksLetPub ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 300 | Yes | CC BY-NC | |
| OpenAlex | USD 300 | — | — | |
| LetPub | USD 300 | Yes | — | |
| Publisher website | USD 1,600 / USD 600 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Keywords
- ≤ 5
- Reference style
- Vancouver
- Templates
- Word
- Suggested reviewers
- Optional
- Not considered
- company data; private letters; catalogues
Article types accepted10, with length limits
- editorialThe journal welcomes four manuscript types, all of which are subject to peer review. Review Papers Review Papers are invited by the Editorial Board to provide c…Length not stated
- letterThe journal welcomes four manuscript types, all of which are subject to peer review. Review Papers Review Papers are invited by the Editorial Board to provide c…Length not stated
- original paperThe journal welcomes four manuscript types, all of which are subject to peer review. Review Papers Review Papers are invited by the Editorial Board to provide c…main text ≤ 4,000 words
- original papersOriginal Papers are descriptions of new and significant research.Length not stated
- research lettersResearch Letters are designed to present and report new concepts, new experimental phenomena, and other new findings or observations that merit early publicatio…Length not stated
- reviewThe journal welcomes four manuscript types, all of which are subject to peer review. Review Papers Review Papers are invited by the Editorial Board to provide c…Length not stated
- review papersReview Papers are invited by the Editorial Board to provide comprehensive and insightful overviews of the latest advances in the field’s technology and research…Length not stated
- surveyThe journal welcomes four manuscript types, all of which are subject to peer review. Review Papers Review Papers are invited by the Editorial Board to provide c…Length not stated
- technical noteThe journal welcomes four manuscript types, all of which are subject to peer review. Review Papers Review Papers are invited by the Editorial Board to provide c…main text ≤ 1,500 words
- technical notesTechnical Notes present information that is useful to ABE readers: for example, system design parameters and experimental results, as well as survey results rel…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints, Self-archiving, Trial registration / reporting guidelines
- AI use Use of artificial intelligence tools
AI tools cannot be authors. Model summary
As per the COPE position statement on Authorship and AI Tools, authors must disclose and fully describe any use of generative or non-generative AI tools (or LLMs) in the Methods section. This includes, but is not limited to, using AI tools to collect or analyze data, produce or amend images or graphics used in the manuscript, or write all or part of the manuscript. Authors must specify which tools…
Source ↗Publisher website ·- Authorship Authorship
ICMJE authorship criteria. Model summary
Authors are responsible for their published work and must follow the International Committee of Medical Journal Editors (ICMJE) Recommendations on ‘Defining the Role of Authors and Contributors’. The journal’s authorship policy follows the four ICMJE author criteria, which are that each author: Contributed substantially to the conception or design of the work, or the acquisition, analysis, or inte…
Source ↗Publisher website ·- Conflicts of interest Conflicts of interest
In the interests of transparency, the journal requires all authors to declare any conflicts of interest in relation to their submitted manuscript. A conflict of interest exists when there are actual, perceived or potential circumstances that could influence an author’s ability to conduct or report research impartially. Potential conflicts include (but are not limited to) competing commercial or fi…
Source ↗Publisher website ·- Data availability Availability of data and materials
Data availability disclosure. Model summary
Authors must disclose the source of publicly available data and materials, such as public repositories or commercial manufacturers, by including accession numbers or company details in their manuscript, as appropriate. Uploading the data to the data repository, J-STAGE Data, is recommended. No additional fee will be charged to authors for uploading data to J-STAGE Data. Authors may make their own …
Source ↗Publisher website ·- Publication ethics
Duplicate submission prohibited. Model summary
Authors must not submit manuscripts that have been previously published (in part or in whole, in any language), or that are in press or under consideration for publication elsewhere.
Source ↗Publisher website ·- License & copyright OPEN ACCESS, COPYRIGHT AND PUBLICATION FEES
ABE is fully Open Access and uses Creative Commons (CC) licenses, which allow users to use, reuse and build upon the material published in the journal without charge or the need to ask prior permission from the publisher or author. Copyright Authors retain copyright in their work, but are required to sign a License to Publish to grant the JSMBE permission to edit and reproduce the work in the jour…
Source ↗Publisher website ·- Open access OPEN ACCESS, COPYRIGHT AND PUBLICATION FEES
ABE is fully Open Access and uses Creative Commons (CC) licenses, which allow users to use, reuse and build upon the material published in the journal without charge or the need to ask prior permission from the publisher or author. Copyright Authors retain copyright in their work, but are required to sign a License to Publish to grant the JSMBE permission to edit and reproduce the work in the jour…
Source ↗Publisher website ·- Peer review PEER REVIEW PROCESS
Single-blind peer review. Model summary
Editorial and peer review process The journal uses single-blind peer review. When a manuscript is submitted to the journal, it is assigned to the Editor-in-Chief, who performs initial screening. Manuscripts that do not fit the journal’s scope or are not deemed suitable for publication are rejected without review. The remaining manuscripts are assigned to one of the journal’s Editorial Board Member…
Source ↗Publisher website ·- Preprints Preprints
Preprint posting encouraged. Model summary
To support the wide dissemination of research, the journal encourages authors to post their research manuscripts on community-recognized preprint servers, either before or alongside submission to the journal. This policy applies only to the original version of a manuscript that describes primary research. Any version of a manuscript that has been revised in response to reviewers’ comments, accepte…
Source ↗Publisher website ·- Self-archiving Self-archiving (Green Open Access) policy
Self-archiving, also known as Green Open Access, enables authors to deposit a copy of their manuscript in an online repository. ABE encourages authors of original research manuscripts to upload their published article to an institutional or public repository immediately after publication in ABE.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal adheres to the International Committee of Medical Journal Editors (ICMJE) policy on Clinical Trials Registration and the CONSORT statement, which recommend that all clinical trials are registered in a public trials registry in a standard format, at or before the time of first patient enrollment, as a condition of consideration for publication. Manuscripts describing clinical trials mus…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Japanese Society for Medical and Biological Engineering
- Country or region
- Japan
- Language
- English
- ISSN
- 2187-5219
- Society / sponsor
- Japanese Society for Medical and Biological Engineering
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Advanced Biomedical Engineering
What CAS zone is Advanced Biomedical Engineering in?
In the 2025 upgraded edition of the CAS Journal Ranking, Advanced Biomedical Engineering is in Zone 4 of Medicine, and in Zone 4 of the minor category Engineering, Biomedical. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Advanced Biomedical Engineering?
Authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Advanced Biomedical Engineering?
According to the journal's author guidelines: Keywords: ≤ 5; Reference style: Vancouver; Templates: Word; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Advanced Biomedical Engineering based?
Of the 69 board members whose country the journal's board page names, 3 (about 4%) are in mainland China; the countries named most often are Japan (47), United States (9) and Mainland China (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Advanced Biomedical Engineering?
According to LetPub and DOAJ records, Advanced Biomedical Engineering is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and INSPEC; that list has not been checked against each database.
Is Advanced Biomedical Engineering open access, and what is the APC?
Advanced Biomedical Engineering is a fully open-access journal. APC about USD 300.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .